Wisconsin Legislature: Drugs

Addiction treatment programs that use methadone: annual report to DHS and physician to review individual’s records before prescribing required [A.Amdt.1: reporting requirements modified, prescription review requirement removed] - AB367

Addiction treatment programs that use methadone: annual report to DHS and physician to review individual’s records before prescribing required - SB271

Administration of prescription drugs to prisoners by correctional officers prohibited unless certain conditions are met; report required - AB835

Administration of prescription drugs to prisoners by correctional officers prohibited unless certain conditions are met; report required - SB611

Billing MA for reimbursement of prescription drugs: covered entities required to charge actual acquisition costs plus dispensing fee - AB311

Billing MA for reimbursement of prescription drugs: covered entities required to charge actual acquisition costs plus dispensing fee [S.Amdt.1: abortion provider specified, definitions provision] - SB238

Controlled substance abuse screening and testing of applicants for Transform Milwaukee Jobs, Transitional Jobs, W-2, and FoodShare employment and training programs: DCF and DHS to implement; waiver, treatment, and JCF provisions - AB191

Corrections System Formulary Board created in Corr.Dept re therapeutic alternate drug selections in the state correctional system - SB84

Corrections System Formulary Board created in Corr.Dept re therapeutic alternate drug selections in the state correctional system - AB120

Declaration of domestic partnership maximum additional fee within 5 days of application modified and legal status required to be completed within 30 days; county clerk requirement revised re providing information on fetal alcohol syndrome and dangers of using drugs while pregnant - AB573

Declaration of domestic partnership maximum additional fee within 5 days of application modified and legal status required to be completed within 30 days; county clerk requirement revised re providing information on fetal alcohol syndrome and dangers of using drugs while pregnant - SB465

Epinephrine auto-injectors: physician, physician assistant, or advanced nurse practitioner may prescribe to an authorized entity, definition provisions; liability exemption for trained employees of authorized entity - AB203

Epinephrine auto-injectors: physician, physician assistant, or advanced nurse practitioner may prescribe to an authorized entity, definition provisions; liability exemption for trained employees of authorized entity [S.Amdt.3: liability provision modified] - SB139

FoodShare employment and training program: DHS to request waiver from USDA, and implement if granted, screening and testing of applicants for illegal use of drugs [Sec. 1833, 9118 (5)] - AB21

FoodShare employment and training program: DHS to request waiver from USDA, and implement if granted, screening and testing of applicants for illegal use of drugs - AB191

FoodShare employment and training program: DHS to request waiver from USDA, and implement if granted, screening and testing of applicants for illegal use of drugs [Sec. 1833, 9118 (5); S.Sub.Amdt.1: further revisions, USDA waiver removed, DHS rule-making authority added, 679c, 1832p] - SB21

Guidelines issued by certain credentialing boards allowed re best practices when prescribing controlled substances; MEB examination authority re physician license applicants - AB660

Guidelines issued by certain credentialing boards allowed re best practices when prescribing controlled substances; MEB examination authority re physician license applicants - SB520

Injectable prescribed drug product or device administered by a pharmacist or pharmacy student expanded - AB865

Injectable prescribed drug product or device administered by a pharmacist or pharmacy student expanded - SB708

Investigational drugs, devices, and biological products: access to by eligible patients and limitation of liability provisions - AB179

Investigational drugs, devices, and biological products: access to by eligible patients and limitation of liability provisions - SB125

Law enforcement agency required to report controlled-substance violations, opioid-related drug overdoses or deaths, reports of stolen prescription drugs, and certain other information to the Prescription Drug Monitoring Program - AB365

Law enforcement agency required to report controlled-substance violations, opioid-related drug overdoses or deaths, reports of stolen prescription drugs, and certain other information to the Prescription Drug Monitoring Program - SB269

MA coverage for substance abuse treatment services by a medically monitored service or transitional residential treatment service [Sec. 1808, 1809] - AB21

MA coverage for substance abuse treatment services by a medically monitored service or transitional residential treatment service [Sec. 1808, 1809] - SB21

Medication for the purpose of ending life: individuals meeting requirements may request from their physicians; DHS duties; does not constitute attempted suicide - AB67

Medication for the purpose of ending life: individuals meeting requirements may request from their physicians; DHS duties; does not constitute attempted suicide - SB28

Opioid addiction treatment pilot program for treating offenders: Corr.Dept to submit plan to JCF [S.Sub.Amdt.1: Sec. 9108 (1d)] - SB21

Opioid antagonists, such as naloxone: clarifications to prescribing, dispensing, and delivery provisions [A.Sub.Amdt.1: further revisions, standing order provisions added] - AB427

Opioid antagonists, such as naloxone: clarifications to prescribing, dispensing, and delivery provisions - SB345

Opioid treatment systems: DHS regulation revisions, counselor provisions [A.Amdt.1: MA reimbursement provision added] - AB659

Opioid treatment systems: DHS regulation revisions, counselor provisions - SB522

Optometrists meeting certain criteria may prescribe or administer certain controlled substances; DSPS rules provision - AB96

Optometrists meeting certain criteria may prescribe or administer certain controlled substances; DSPS rules provision - SB74

Pain clinic certification provisions created, requirements specified; DHS duties [A.Sub.Amdt.1: further revisions; A.Amdt.1: payment method revised and MEB provision added] - AB366

Permit to state crime laboratory to possess, manufacture, or use a controlled substance modified - AB776

Permit to state crime laboratory to possess, manufacture, or use a controlled substance modified - SB623

Personal care product containing microbeads: manufacture and sale prohibitions created; over-the-counter drug and ordinance provisions - AB15

Personal care product containing microbeads: manufacture and sale prohibitions created; over-the-counter drug and ordinance provisions - SB15

Personal care product containing microbeads: manufacture, sale, and distribution prohibitions created; over-the-counter drug provision - SB18

Pharmacy benefit manager pricing transparency requirements created, definition provisions [S.Sub.Amdt.1: Sec. 4590p, 9422 (2j)] - SB21

Prescription drug assistance for elderly program: waiver of federal Medicaid law required and use of excess GPR and PR moneys - AB211

Prescription drug assistance for elderly program: waiver of federal Medicaid law required and use of excess GPR and PR moneys - SB142

Prescription drug assistance for the elderly program: Medicare Part D added to eligibility requirements [Sec. 1828, 1829, 9118 (4)] - AB21

Prescription drug assistance for the elderly program: Medicare Part D added to eligibility requirements [Sec. 1828, 1829, 9118 (4); original bill only] - SB21

Prescription drug monitoring program changes re timing of submission of records and disclosure of records; emergency rule provision [A.Amdt.1: review of patient's records exemptions, veterinarian prescription orders included, DSPS Secretary to notify LRB when the program is operational; A.Amdt.2: disclosure of records cannot contain patient's personally identifiable information] - AB364

Prescription drug monitoring program changes re timing of submission of records and disclosure of records; emergency rule provision - SB268

Prescription drug monitoring program review and reporting requirements created, sunset provision [A.Amdt.1: CSB may contract with an analytics firm to augment the program] - AB766

Prescription drug monitoring program review and reporting requirements created, sunset provision - SB716

Prescription drug monitoring program transferred to CSB from the Pharmacy Examining Board; rule provisions re record disclosure and failure to comply; CSB membership modified [Sec. 175, 524, 3483, 4474, 4477, 9138 (1)] - AB21

Prescription drug monitoring program transferred to CSB from the Pharmacy Examining Board; rule provisions re record disclosure and failure to comply; CSB membership modified [Sec. 175, 524, 3483, 4474, 4477, 9138 (1); S.Sub.Amdt.1: further revisions, definition provisions, 4731f-k] - SB21

Prescription refills: pharmacist may dispense varying quantities under certain conditions [A.Sub.Amdt.1: further revisions, applies to refills and not initial fills, excludes controlled substances, limited to 90-day supply] - AB866

Prescription refills: pharmacist may dispense varying quantities under certain conditions - SB709

Psychotropic medication: signed acknowledgement form requirements for administration to CBRF residents; off premises and nursing home provisions - AB791

Psychotropic medication: signed acknowledgement form requirements for administration to CBRF residents; off premises and nursing home provisions - SB748

Spiritual treatment in lieu of medical or surgical treatment for children: exemptions removed re county department determination of child abuse or neglect, felony physical abuse of a child, and administration of psychotropic medication to juveniles in correctional custody; Christian Science treatment limited to adult patients - AB959

Substance abuse screening and testing required for certain job training and work experience programs; substance abuse treatment provision [Sec. 1739, 1740, 1742, 1789, 1790, 9306 (3)] - AB21

Substance abuse screening and testing required for certain job training and work experience programs; substance abuse treatment provision [Sec. 1739, 1740, 1742, 1789, 1790, 9306 (3); S.Sub.Amdt.1: further revisions, appropriation and DCF rule authority added, 723n, 9106 (2c), deletes 9306 (3)] - SB21

UI benefit applicants: DWD to establish drug testing program, rules provision; survey of employers, voluntary submission of test results by employing unit, and unemployment reserve fund balancing account provisions - AB192

UI benefit applicants: DWD to establish drug testing program, rules provision; voluntary submission by employing unit [Sec. 725, 726, 3111, 3112, 3115, 3116, 3119, 3120, 9151 (5); S.Sub.Amdt.1: further revisions, deletes 725] - SB21

UI benefit applicants: DWD to establish drug testing program, rules provision; voluntary submission by employing unit [Sec. 725, 726, 3111, 3112, 3115, 3116, 3119, 3120, 9151 (5)] - AB21

Volunteer Health Care Provider Program, opioid treatment program, Well-Woman Program provision (remedial legislation) - AB679

Volunteer Health Care Provider Program, opioid treatment program, Well-Woman Program provision (remedial legislation) - SB554

WC law revisions re general coverage, payment of benefits, hearing and procedures, and program administration; study of restricted work during employee healing period required; DHA, LIRC, DOJ, and DWD duties - AB501

WC law revisions re general coverage, payment of benefits, hearing and procedures, and program administration; self-insurer provisions; DWD, LIRC, DHA, and DOJ duties [A.Amdt.1: certain employees of newspapers or magazines provision added] - AB724

WC law revisions re general coverage, payment of benefits, hearing and procedures, and program administration; study of restricted work during employee healing period required; DHA, LIRC, DOJ, and DWD duties - SB456

WC law revisions re general coverage, payment of benefits, hearing and procedures, and program administration; self-insurer provisions; DWD, LIRC, DHA, and DOJ duties - SB536

Cannabidiol (CBD oil) producers re treatment for seizure disorder: licensure program in DSPS established; possession and dispensing requirements modified - SB772

Capitol Police commended for implementing a Naloxone program that allowed Officer Chris Litzkow to save a man’s life - AJR93

DOJ grants to Lafayette County Sheriff's Department for drug law enforcement and drug interdiction services [A.Amdt.2: grant amount reduced] - AB771

Drinking age report, effective date of REAL ID Act, occupational tax on illegal controlled substances repealed (remedial legislation) - AB684

Drinking age report, effective date of REAL ID Act, occupational tax on illegal controlled substances repealed (remedial legislation) - SB559

Drug law enforcement and interdiction grant to the Lafayette County Sheriff's Department [S.Sub.Amdt.1: Sec. 9126 (1q)] - SB21

Heroin metabolite added to ``restricted controlled substance” definition re chemical tests for intoxication - AB557

Heroin metabolite added to ``restricted controlled substance” definition re chemical tests for intoxication - SB643

Law enforcement agency required to report controlled-substance violations, opioid-related drug overdoses or deaths, reports of stolen prescription drugs, and certain other information to the Prescription Drug Monitoring Program - AB365

Law enforcement agency required to report controlled-substance violations, opioid-related drug overdoses or deaths, reports of stolen prescription drugs, and certain other information to the Prescription Drug Monitoring Program - SB269

Marijuana: elimination of criminal penalty for possession of 25 grams or less - AB246

Marijuana: elimination of criminal penalty for possession of 25 grams or less - SB167

Marijuana: state law changed to allow recreational and medical use of; restrictions, permits, taxation, medical registry, compassion centers, and penalties specified; OWI provision; DHS duties - AB224

Masking agent re lawfully administered drug test: use, possession, manufacture, distribution, and advertising of made a crime - AB658

Masking agent re lawfully administered drug test: use, possession, manufacture, distribution, and advertising of made a crime - SB499

Medical marijuana registry created and DHS duties; medical use defense to prosecutions, ID cards, dispensaries, testing laboratories, discrimination, background checks, fees, penalties, and local government provisions - SB789

Nonfelony possession of marijuana offenses: court to order expungement under set conditions - AB944

Possession of marijuana after conviction for Uniform Controlled Substances Act violation: penalty reduced; except if it occurred on school grounds, person carried a dangerous weapon, force was used, or someone suffered death or great bodily harm - AB945